Blog

  1. A day in the life of CiteAb software developer Rob

    Rob Willison joined CiteAb over the summer as our new software developer, working closely with the team at Storm who initially developed our platform and will continue to support it. Rob is not completely new to CiteAb – he joined us from his degree at the University of Bath, where he did a computer science […]

  2. Further evidence shows why you must ALWAYS validate antibodies!

    We recently blogged about validating your antibodies, and a lot of you got in touch to share your experiences and also suggest another study we should feature here on our blog. Our last validation blog pointed out that while our team here at CiteAb aims to help you find the best potential antibodies for your […]

  3. The awards are back!

    We’re currently working with our product team to launch the 2018 CiteAb Awards, featuring some brand new categories. The awards aim to celebrate the very best suppliers and individuals in the sector, recognising the efforts that are made to progress science. Our founder, Dr Andrew Chalmers, said: “We’ve added a few new members to the […]

  4. A day in the life of CiteAb product manager Alicia

    Alicia Cooper joined our team this summer as one of our two new data product managers. Today we introduce Alicia and give you an insight into the work she does with us here, and learn about how we can expect her to keep us all supplied with baked goodies over the winter! Alicia graduated from […]

  5. Which are the key antibody companies to watch?

    Last week we released our annual update on the global antibody supplier market, outlining those companies that have recently entered or neared the top ten, and have grown their share of the global market by over one per cent in the last year. Today we address another interesting part of this dataset – the companies […]

  6. Which antibody suppliers are challenging the big players?

    Today we’re releasing our updated antibody supplier market share dataset, ranking suppliers based on their global citation share. In the full dataset we cover market share for all suppliers, however on our blog today we are focusing on companies that have managed to grow from fairly lowly positions in the ranking, and capture more than […]

  7. A day in the life of CiteAb product manager Rebecca

    Rebecca Sadler joined our team this summer as one of our two new product managers. Today we introduce Rebecca and give you an insight into the work she does with us here, and we chat to her about her exciting new hobby! Rebecca graduated from her biology degree at the University of Bath earlier in […]

  8. You must ALWAYS validate – and this is why

    As you know, here at CiteAb we aim to help you find the best potential antibodies for your experiments, but that doesn’t mean that you don’t still need to validate them when you get them. This need has recently been highlighted with the publishing of a new research paper by Sandra Andersson from the Department […]

  9. Discover the most used anti-chemical antibodies

    Our new data released today focuses on the top anti-chemical antibodies and their targets. The majority of antibodies are raised against proteins – but some are raised against other molecules, which we term anti-chemical antibodies. CiteAb Product Manager Rhys Williams said: “To produce this dataset we looked at 2700 citations for antibodies raised against chemicals, […]

  10. Revealed: The top 100 cited antibodies of 2016

    New data from CiteAb reveals that just nine companies supply the top 100 antibodies cited over the whole of 2016. In addition, one single company is responsible for the supply of 38 of these antibodies. Dr Andrew Chalmers, founder of CiteAb, said: “This data comes from a set that shows trends in citation rates for […]